Skip to content

Comparing different medicines for preventing fits/seizures /convulsions in accident patients

Comparison of phenytoin aand leveteracitam for prophylaxis of seizures in the early postoperative period in TBI patients-a pilot study - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/060169
Enrollment
30
Registered
2023-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S069- Unspecified intracranial injury

Interventions

Intervention1: Leveteracetam: Antiepileptic drug, 500mg BD,via intravenous route, for 7 days Control Intervention1: Phenytoin: Antiepileptic agent, 100mg TID, via intravenous route, for 7 days

Sponsors

Hospital supplyfree of cost Sherikashmir institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Pts 18yrs or above 2)Pts with diagnosis of TBI 3)GCS less than 8

Exclusion criteria

Exclusion criteria: 1)Pts with history of epilepsy or seizure disorder. 2)Pt with history of hypersensitivity or allergy to phenytoin or leviteracetam. 3)Pt with history of liver or kidney disease. 4)Pts who are pregnant or breast feeding. 5)Pts who don’t give consent

Design outcomes

Primary

MeasureTime frame
1)Time to first seizure 2)total seizures during 7 days Timepoint: During 7 days

Secondary

MeasureTime frame
No. of days of icu stay. No. of days of hospital stayTimepoint: Till patient is discharged.

Countries

India

Contacts

Public ContactDr Eman Aftab

Sheri-I-Kashmir Institute of Medical sciences

zulfiqaraliiii@yahoo.com9419086761

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026